Clinical Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

About the Cover

Cover Figure


The TP53 tumor suppressor gene is located at 17p13.1. 17p13 allelic losses are very frequent in adrenocortical cancer, and somatic mutations of TP53 are observed in a third of these neoplasms. In malignant adrenocortical tumors, somatic TP53 mutations are associated with p53 accumulation, as determined by immunohistochemistry. The larger figure shows a nuclear staining for p53 in an adrenocortical cancer with a TP53 mutation. By contrast, the smaller figure shows that staining for p53 is not significant in a tumor without TP53 mutation (<1% of cells). For further details, please see Libè et al. on page 844 of this issue.

[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.